Eric King

Eric King has over 20 years of experience in the technology sector, beginning in 2000 when they were an Investment Manager at Intel Capital. In 2006, they moved to InnoPath Software as VP, OEM Sales & Business Development. In 2012, they returned to Intel Corporation as Director, Strategic Business Development for Intel's Client and Internet of Things (IoT) Businesses and Systems Architecture Group (CISA). In 2017, they rejoined Intel Capital as Venture Investments. In 2019, they began investing in and serving as Board Director for Retrace, eXo Imaging, Inc., and Medical Informatics Corp. In 2021, they became an Investor and Board Observer for Caresyntax. In 2022, they joined SaVia Health as an Investor and Board Director and Biofourmis as an Investor.

Eric King received their MBA in Business Administration & Finance from Brigham Young University.